A Novel Role for RARα Agonists as Apolipoprotein CIII Inhibitors Identified from High Throughput Screening
Abstract Elevated triglyceride (TG) levels are well-correlated with the risk for cardiovascular disease (CVD). Apolipoprotein CIII (ApoC-III) is a key regulator of plasma TG levels through regulation of lipolysis and lipid synthesis. To identify novel regulators of TG levels, we carried out a high t...
Guardado en:
Autores principales: | Sang Jun Lee, Madhupriya Mahankali, Abdallah Bitar, Huafei Zou, Elizabeth Chao, Hung Nguyen, Jose Gonzalez, Dawna Caballero, Mitch Hull, Danling Wang, Peter G. Schultz, Weijun Shen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3ea9011fb70b4cf78139664545c9293e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
APOE genotype influences insulin resistance, apolipoprotein CII and CIII according to plasma fatty acid profile in the Metabolic Syndrome
por: Rosalind Fallaize, et al.
Publicado: (2017) -
Targeting the acute promyelocytic leukemia-associated fusion proteins PML/RARα and PLZF/RARα with interfering peptides.
por: Sabine Beez, et al.
Publicado: (2012) -
RARα supports the development of Langerhans cells and langerin-expressing conventional dendritic cells
por: Seika Hashimoto-Hill, et al.
Publicado: (2018) -
ApoCIII enrichment in HDL impairs HDL-mediated cholesterol efflux capacity
por: Mengdie Luo, et al.
Publicado: (2017) -
The quaternary architecture of RARβ–RXRα heterodimer facilitates domain–domain signal transmission
por: Vikas Chandra, et al.
Publicado: (2017)